BrightSpring Swings to Profit on Robust Revenue Growth

TL;DR

**BrightSpring is back in the black with massive revenue growth, making it a strong buy as they streamline operations.**

AI Summary

BrightSpring Health Services, Inc. reported a significant turnaround in its financial performance for the nine months ended September 30, 2025, achieving a net income of $111.79 million, a substantial improvement from a net loss of $35.93 million in the same period of 2024. Total revenues increased by 27.77% to $9.36 billion in 2025 from $7.33 billion in 2024, driven by a 30.39% rise in product revenues to $8.29 billion and a 10.61% increase in service revenues to $1.07 billion. Operating income saw a dramatic increase, reaching $187.14 million in 2025 compared to $52.42 million in 2024, representing a 257.02% growth. The company's cash and cash equivalents more than doubled, from $60.95 million at December 31, 2024, to $140.34 million at September 30, 2025. Accounts receivable also grew by 12.20% to $1.01 billion, indicating strong sales but also potential for collection delays. A key strategic change is the pending sale of its Community Living business, with current assets held for sale increasing from $131.45 million to $863.85 million, and non-current assets held for sale decreasing from $687.96 million to zero, reflecting reclassification. Risks include reliance on Medicare and Medicaid rates, cost containment initiatives by third-party payors, and the ability to retain qualified personnel.

Why It Matters

BrightSpring's return to profitability and significant revenue growth signals a strong operational recovery and expansion, which is crucial for investor confidence. The substantial increase in cash and cash equivalents provides greater liquidity and flexibility for future investments or debt reduction. For employees, sustained growth could mean job security and opportunities, while customers may benefit from expanded services. In the competitive healthcare services market, BrightSpring's performance indicates it is effectively navigating industry challenges and potentially gaining market share, especially with the strategic divestiture of its Community Living business allowing for greater focus on core operations.

Risk Assessment

Risk Level: medium — The company's risk level is medium due to its substantial indebtedness, with long-term debt (net of current portion) at $2.47 billion as of September 30, 2025. While net income improved, the business remains highly dependent on government programs like Medicare and Medicaid, which are subject to rate changes and cost containment initiatives, as explicitly stated in the forward-looking statements.

Analyst Insight

Investors should consider BrightSpring's strong revenue growth and return to profitability as a positive indicator. The strategic sale of the Community Living business suggests a focus on higher-margin or more scalable operations. Monitor the integration of any new acquisitions and the impact of the divestiture on future earnings, as well as the company's ability to manage its significant debt load.

Financial Highlights

revenue

$9.36B

total Debt

$2.47B

net Income

$111.79M

eps

$0.52

cash Position

$140.34M

revenue Growth

+27.77%

Revenue Breakdown

Key Numbers

• $111.79M — Net Income (Swung from a $35.93M net loss in 2024 to a profit in 2025 for the nine-month period.)
• $9.36B — Total Revenues (Increased by 27.77% from $7.33B in 2024 for the nine-month period.)
• $187.14M — Operating Income (Increased by 257.02% from $52.42M in 2024 for the nine-month period.)
• $140.34M — Cash and Cash Equivalents (More than doubled from $60.95M at December 31, 2024.)
• $2.47B — Long-term Debt (Net of current portion, as of September 30, 2025, indicating significant leverage.)
• $863.85M — Current Assets Held for Sale (Increased from $131.45M, reflecting reclassification for the pending Community Living business sale.)
• 27.77% — Revenue Growth (Year-over-year increase in total revenues for the nine-month period.)
• 257.02% — Operating Income Growth (Year-over-year increase in operating income for the nine-month period.)
• $0.52 — Diluted EPS (For the nine months ended September 30, 2025, compared to $(0.18) in 2024.)

Key Players & Entities

• BrightSpring Health Services, Inc. (company) — Registrant as Specified in its Charter
• Nasdaq Stock Market LLC (regulator) — Exchange where Common Stock and Tangible Equity Units are registered
• SEC (regulator) — U.S. Securities and Exchange Commission
• KKR Stockholder (company) — Entity whose interests may conflict with stockholders
• $111,793 (dollar_amount) — Net income for the nine months ended September 30, 2025
• $35,925 (dollar_amount) — Net loss for the nine months ended September 30, 2024
• $9,359,933 (dollar_amount) — Total revenues for the nine months ended September 30, 2025
• $7,325,249 (dollar_amount) — Total revenues for the nine months ended September 30, 2024
• $187,139 (dollar_amount) — Operating income for the nine months ended September 30, 2025
• $2,465,334 (dollar_amount) — Long-term debt, net of current portion, as of September 30, 2025

FAQ

Risk Factors

• Medicare and Medicaid Reimbursement Rates [high — regulatory]: The company's financial performance is heavily reliant on reimbursement rates from government programs like Medicare and Medicaid. Changes or reductions in these rates could materially impact revenue and profitability.
• Third-Party Payer Cost Containment [medium — market]: Third-party payors, including commercial insurers, are increasingly implementing cost containment measures. This could lead to lower reimbursement rates or increased scrutiny on claims, affecting revenue and operating margins.
• Personnel Retention [medium — operational]: The ability to attract and retain qualified personnel, particularly in healthcare services, is critical. Shortages or high turnover of skilled staff can disrupt service delivery and increase operating costs.
• Leverage and Debt Obligations [high — financial]: With $2.47 billion in long-term debt (net of current portion) as of September 30, 2025, the company carries significant financial leverage. Servicing this debt requires substantial cash flow and could limit financial flexibility.
• Liquidity and Cash Position [medium — financial]: While cash and cash equivalents more than doubled to $140.34 million, this level may still be considered modest relative to the company's scale and debt obligations, especially considering potential operational fluctuations.
• Divestiture of Community Living Business [medium — strategic]: The pending sale of the Community Living business, reflected in the significant increase in 'assets held for sale' to $863.85 million, introduces execution risk. The success of this divestiture is crucial for strategic realignment and potential debt reduction.

Industry Context

BrightSpring Health Services operates in the dynamic healthcare services sector, characterized by increasing demand for home and community-based care, alongside evolving reimbursement models. The industry faces significant regulatory oversight and pressure to control costs from both government and private payers.

Regulatory Implications

The company's substantial reliance on Medicare and Medicaid reimbursement rates makes it highly susceptible to changes in government healthcare policy and funding. Cost containment initiatives by third-party payors also pose a significant challenge to revenue and margin stability.

What Investors Should Do

1. Monitor the progress and terms of the Community Living business divestiture.
2. Analyze the sustainability of the recent revenue and operating income growth.
3. Assess the company's ability to manage its significant long-term debt ($2.47B).
4. Evaluate the impact of potential changes in Medicare and Medicaid reimbursement rates.

Key Dates

• 2025-09-30: Nine months ended September 30, 2025 — Reported significant financial turnaround with net income of $111.79M and revenue of $9.36B.
• 2024-09-30: Nine months ended September 30, 2024 — Reported a net loss of $35.93M and revenue of $7.33B, highlighting the substantial year-over-year improvement.
• 2025-12-31: As of December 31, 2024 — Cash and cash equivalents were $60.95M, providing a baseline for the significant increase observed by September 30, 2025.

Glossary

Assets Held for Sale

Assets that a company intends to sell within one year. They are typically reported separately on the balance sheet and valued at the lower of their carrying amount or fair value less costs to sell. (Indicates the company's strategic decision to divest its Community Living business, with a significant increase to $863.85M.)

Operating Income

A measure of a company's profit after deducting operating expenses from its revenue. It reflects the profitability of the core business operations. (Showed a dramatic increase of 257.02% to $187.14M, signaling strong operational performance improvement.)

Diluted EPS

Earnings per share calculated using the weighted average number of outstanding common shares and dilutive potential common shares. It represents the earnings attributable to each share of common stock. (Improved from $(0.18) in 2024 to $0.52 in 2025, reflecting enhanced profitability on a per-share basis.)

Year-Over-Year Comparison

BrightSpring Health Services has demonstrated a remarkable financial recovery in the nine months ended September 30, 2025, compared to the same period in 2024. Total revenues surged by 27.77% to $9.36 billion, while operating income saw an exceptional 257.02% increase to $187.14 million, swinging from a net loss to a net income of $111.79 million. This turnaround is accompanied by a significant increase in assets held for sale, reflecting a strategic divestiture, and a more than doubling of cash reserves. New risks related to the divestiture execution and continued reliance on government reimbursement rates are prominent.

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share 6.75% Tangible Equity Units

Filing Documents

• btsg-20250930.htm (10-Q) — 5054KB
• btsg-ex31_1.htm (EX-31.1) — 20KB
• btsg-ex31_2.htm (EX-31.2) — 20KB
• btsg-ex32_1.htm (EX-32.1) — 13KB
• btsg-ex32_2.htm (EX-32.2) — 13KB
• 0001193125-25-253631.txt ( ) — 18078KB
• btsg-20250930.xsd (EX-101.SCH) — 1802KB
• btsg-20250930_htm.xml (XML) — 4100KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated Statements of Comprehensive Income (Loss) 5 Condensed Consolidated Statements of Shareholders' Equity 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 28 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 48 Item 4.

Controls and Procedures

Controls and Procedures 49 PART II. OTHER INFORMATION 50 Item 1.

Legal Proceedings

Legal Proceedings 50 Item 1A.

Risk Factors

Risk Factors 50 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 50 Item 3. Defaults Upon Senior Securities 50 Item 4. Mine Safety Disclosures 50 Item 5. Other Information 50 Item 6. Exhibits 51

Signatures

Signatures 52 i Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q (this "Form 10-Q") to "BrightSpring," the "Company," "we," "us," and "our" refer to BrightSpring Health Services, Inc. and its consolidated subsidiaries.

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q includes forward-looking statements that reflect our current views with respect to, among other things, our operations, and financial performance. We have used the words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases to identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our industries, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. We believe that these factors include but are not limited to the following: our operation in a highly competitive industry; our inability to maintain relationships with existing patient referral sources or establish new referral sources; changes to Medicare and Medicaid rates or methods governing Medicare and Medicaid payments for our services; cost containment initiatives of third-party payors, including post-payment audits; the implementation of alternative payment models and the transition of Medicaid and Medicare beneficiaries to managed care organizations may limit our market share and could adversely affect our revenues; changes in the case mix of patients, as well as payor mix and payment methodologies, and decisions and operations of third-party organizations; our reliance on federal and state spending, budget decisions, and continuous governmental operations which may fluctuate under different political conditions; changes in drug utilization and/or pricing, PBM contracts, and Medicare Part D/Medicaid rei

—FIN ANCIAL INFORMATION

PART I—FIN ANCIAL INFORMATION Ite m 1. Financial Statements. BrightSpring Health Services, Inc. and Subsidiaries Condensed Consolida ted Balance Sheets (In thousands, except share and per share data) (Unaudited) September 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 140,344 $ 60,954 Accounts receivable, net of allowance for credit losses 1,012,913 902,782 Inventories 639,195 636,561 Prepaid expenses and other current assets 123,978 161,310 Current assets held for sale 863,846 131,447 Total current assets 2,780,276 1,893,054 Property and equipment, net of accumulated depreciation of $ 387,921 and $ 339,892 at September 30, 2025 and December 31, 2024, respectively 175,494 180,570 Goodwill 2,370,566 2,363,884 Intangible assets, net of accumulated amortization 521,610 595,224 Operating lease right-of-use assets, net 159,589 161,032 Deferred income taxes, net — 5,288 Other assets 41,962 39,128 Non-current assets held for sale — 687,960 Total assets $ 6,049,497 $ 5,926,140 Liabilities, Redeemable Noncontrolling Interest, and Equity Current liabilities: Trade accounts payable $ 954,497 $ 923,926 Accrued expenses 304,046 295,746 Current portion of obligations under operating leases 38,217 38,910 Current portion of obligations under financing leases 4,727 3,463 Current portion of long-term debt 51,870 48,725 Current liabilities held for sale 196,613 117,563 Total current liabilities 1,549,970 1,428,333 Obligations under operating leases, net of current portion 128,751 129,467 Obligations under financing leases, net of current portion 10,423 6,530 Long-term debt, net of current portion 2,465,334 2,561,858 Deferred income taxes, net 10,441 — Long-term liabilities 63,560 71,190 Non-current liabilities held for sale — 77,177 Total liabilities 4,228,

View Full Filing

View this 10-Q filing on SEC EDGAR